India, Nov. 14 -- Novo Nordisk (NVO) presented new real-world data at ObesityWeek 2026 suggesting that Wegovy (semaglutide) may help reduce "food noise," an emerging obesity-care concept describing persistent, intrusive and unwanted thoughts about food.
The findings came from the SIGNAL and OCTANE studies, which evaluated changes in self-reported food noise among adults with overweight or obesity taking either injectable or oral semaglutide in a real-world telehealth setting.
In the SIGNAL study, which included more than 26,000 treatment-naive adults with obesity or overweight and at least one weight-related condition, food noise scores declined significantly within the first month of starting injectable semaglutide. The greatest improvem...